United States· US:0143-9559_9d3d08d4-ce59-49e2-b8be-0ac1204e33e5
Argatroban
A medicinal product containing argatroban, registered in United States by Hikma Pharmaceuticals USA Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Argatroban
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- June 3, 2026
Packs & prices · 1
- ndc1101439559011 VIAL in 1 CARTON (0143-9559-01) / 50 mL in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Argatroban in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyArgatraEthypharm
- FranceARGANOVA 1 mg/mL, solution pour perfusionETHYPHARM
- FinlandNovastanOrifarm Oy
- United KingdomArgatroban 50mg/50ml solution for infusion vialsAccord-UK Ltd
- SwedenNovastan 1 mg/ml Infusionsvätska, lösningEthypharm
- SwitzerlandArgatra 100mg/ml, Konzentrat zur Herstellung einer InfusionslösungMedius AG
- NetherlandsArganova Multidose 100 mg/ml concentraat voor oplossing voor infusieEthypharm
- NorwayExembol MultidoseEthypharm
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Argatra, Argatra Multidose
- Germany · Argatra, Argatra Multidose
- Denmark · Novastan
- Spain · Arganova
- Finland · Novastan
- France · Arganova, Argatroban Accord
- United Kingdom (Northern Ireland) · Argatroban Accord Healthcare, Exembol
- Italy · Novastan
- Netherlands · Arganova Multidose
- Norway · Novastan
- Sweden · Novastan, Novastan Multidos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f07d8fc8-0527-421e-9f2b-85995151a993 GET /v1/drugs/f07d8fc8-0527-421e-9f2b-85995151a993?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"productid": "0143-9559_9d3d08d4-ce59-49e2-b8be-0ac1204e33e5",
"productndc": "0143-9559",
"dosage_form": "INJECTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "ARGATROBAN",
"proprietary_name": "Argatroban",
"active_ingred_unit": "mg/50mL",
"application_number": "NDA203049",
"marketing_category": "NDA",
"nonproprietary_name": "Argatroban",
"start_marketing_date": "20161101",
"active_numerator_strength": "50"
}See everything about argatroban.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.